Theseus Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $54,086,000.
Profit Margin
| 2019 | 0 | -7.18M | |
|---|---|---|---|
| 2020 | 0 | -11.99M | |
| 2021 | 0 | -27.30M | |
| 2022 | 0 | -47.08M |
THRX Income Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 438K | 2K | 2K | 2K |
Gross profit | -438K | -2K | -2K | -2K |
Operating exp. | ||||
Research and development | 35.69M | 18.32M | 5.95M | 4.12M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 54.08M | 27.33M | 6.83M | 4.94M |
Operating income | -54.08M | -27.33M | -6.83M | -4.94M |
Other income (expenses), net | 3.47M | 28K | -5.16M | -2.24M |
Income before tax | -50.60M | -27.30M | -11.99M | -7.18M |
Income tax expense | -3.52M | 0 | 0 | 0 |
Net income | -47.08M | -27.30M | -11.99M | -7.18M |
Earnings per share | ||||
Basic EPS | -1.22 | -2.84 | -0.47 | -0.6 |
Diluted EPS | -1.22 | -2.84 | -0.47 | -0.6 |
| Data source | Data source |